» Articles » PMID: 18562394

Multi-state Models for the Analysis of Time-to-event Data

Overview
Publisher Sage Publications
Specialties Public Health
Science
Date 2008 Jun 20
PMID 18562394
Citations 146
Authors
Affiliations
Soon will be listed here.
Abstract

The experience of a patient in a survival study may be modelled as a process with two states and one possible transition from an "alive" state to a "dead" state. In some studies, however, the "alive" state may be partitioned into two or more intermediate (transient) states, each of which corresponding to a particular stage of the illness. In such studies, multi-state models can be used to model the movement of patients among the various states. In these models issues, of interest include the estimation of progression rates, assessing the effects of individual risk factors, survival rates or prognostic forecasting. In this article, we review modelling approaches for multi-state models, and we focus on the estimation of quantities such as the transition probabilities and survival probabilities. Differences between these approaches are discussed, focussing on possible advantages and disadvantages for each method. We also review the existing software currently available to fit the various models and present new software developed in the form of an R library to analyse such models. Different approaches and software are illustrated using data from the Stanford heart transplant study and data from a study on breast cancer conducted in Galicia, Spain.

Citing Articles

Cardio and cerebrovascular diseases risk among Alzheimer's disease patients and racial/ethnic disparities, based on Hawaii Medicare data.

Siriwardhana C, Carrazana E, Liow K, Chen J J Alzheimers Dis Rep. 2025; 8(1):1529-1540.

PMID: 40034347 PMC: 11864236. DOI: 10.1177/25424823241289038.


A discrete-time split-state framework for multi-state modeling with application to describing the course of heart disease.

Ding M, Chen H, Lin F BMC Med Res Methodol. 2025; 25(1):54.

PMID: 40021971 PMC: 11869649. DOI: 10.1186/s12874-025-02512-6.


Association of accelerated phenotypic aging, genetic risk, and lifestyle with progression of type 2 diabetes: a prospective study using multi-state model.

Pan L, Liu Y, Huang C, Huang Y, Lin R, Wei K BMC Med. 2025; 23(1):62.

PMID: 39901253 PMC: 11792689. DOI: 10.1186/s12916-024-03832-y.


Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver Transplantation.

Aziz B, Kok B, Cheah M, Lytvyak E, Moctezuma-Velazquez C, Wasilenko S Am J Gastroenterol. 2025; 120(2):459-468.

PMID: 39888688 PMC: 11774198. DOI: 10.14309/ajg.0000000000002977.


Transitions through the HIV continuum of care in people enrolling in care with advanced HIV disease in Latin America.

Belaunzaran-Zamudio P, Rebeiro P, Caro-Vega Y, Castilho J, Crabtree-Ramirez B, Cesar C IJID Reg. 2025; 14:100550.

PMID: 39877417 PMC: 11772978. DOI: 10.1016/j.ijregi.2024.100550.


References
1.
Saint-Pierre P, Combescure C, Daures J, Godard P . The analysis of asthma control under a Markov assumption with use of covariates. Stat Med. 2003; 22(24):3755-70. DOI: 10.1002/sim.1680. View

2.
Aalen O, Borgan O, Fekjaer H . Covariate adjustment of event histories estimated from Markov chains: the additive approach. Biometrics. 2002; 57(4):993-1001. DOI: 10.1111/j.0006-341x.2001.00993.x. View

3.
Glidden D . Robust inference for event probabilities with non-Markov event data. Biometrics. 2002; 58(2):361-8. DOI: 10.1111/j.0006-341x.2002.00361.x. View

4.
Pencina M, Larson M, DAgostino R . Choice of time scale and its effect on significance of predictors in longitudinal studies. Stat Med. 2006; 26(6):1343-59. DOI: 10.1002/sim.2699. View

5.
Marshall G, Guo W, Jones R . MARKOV: a computer program for multi-state Markov models with covariables. Comput Methods Programs Biomed. 1995; 47(2):147-56. DOI: 10.1016/0169-2607(95)01641-6. View